Cargando…

Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND AND AIMS: Traditional Chinese medicine (TCM) therapy for hepatocellular carcinoma remains controversial. This study aimed to evaluate the efficacy and safety of TCM regimens in HCC treatment. METHODS: Randomized controlled trials (RCTs) up to June 1, 2016, of the TCM treatment for hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zongguo, Liao, Xian, Lu, Yunfei, Xu, Qingnian, Tang, Bozong, Chen, Xiaorong, Yu, Yongchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478821/ https://www.ncbi.nlm.nih.gov/pubmed/28680448 http://dx.doi.org/10.1155/2017/3428253

Ejemplares similares

Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Yang, Zongguo, et al.
Publicado: (2016)

HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus
por: Yang, Zongguo, et al.
Publicado: (2015)

Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Tang, Bozong, et al.
Publicado: (2016)

Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization
por: Yang, Zongguo, et al.
Publicado: (2015)

Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
por: Liu, Cheng, et al.
Publicado: (2015)

Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
por: Liu, Cheng, et al.
Publicado: (2022)

Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients
por: Yang, Zongguo, et al.
Publicado: (2020)

Firmicutes and Blautia in gut microbiota lessened in chronic liver diseases and hepatocellular carcinoma patients: a pilot study
por: Chen, Tianyou, et al.
Publicado: (2021)

Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2014)

Upregulation of Heat Shock Proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in Tumour Tissues Is Associated with Poor Outcomes from HBV-Related Early-Stage Hepatocellular Carcinoma
por: Yang, Zongguo, et al.
Publicado: (2015)

Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study
por: Chen, Xiaorong, et al.
Publicado: (2013)

Adverse Events Associated with Metal Contamination of Traditional Chinese Medicines in Korea: A Clinical Review
por: Kim, Hyunah, et al.
Publicado: (2014)

The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis
por: Zhang, Yuan, et al.
Publicado: (2020)

Traditional Chinese Medicine treatment of COVID-19
por: Xu, Jia, et al.
Publicado: (2020)

Observational Studies on Evaluating the Safety and Adverse Effects of Traditional Chinese Medicine
por: Lai, Jung-Nein, et al.
Publicado: (2013)

Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats
por: Chen, Xiaorong, et al.
Publicado: (2012)

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma
por: Shi, Jia, et al.
Publicado: (2019)

Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
por: Xi, Sheng-Yan, et al.
Publicado: (2018)

Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
por: Yao, Man, et al.
Publicado: (2023)

Activation of apoptosis in hepatocellular carcinoma by the Chinese traditional medicine Hu Qisan
por: ZENG, XIANGJUN, et al.
Publicado: (2013)

The Benefit of Enhanced Daycare of Traditional Chinese Medicine for Cancer Treatment Related Adverse Events: A Retrospective Study of Medical Records
por: Wu, Hsiu-An, et al.
Publicado: (2021)

Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
por: Wei, Lai, et al.
Publicado: (2022)

Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine
por: Zhang, Yaxing, et al.
Publicado: (2021)

Direct and indirect therapeutic effect of traditional Chinese medicine as an add-on for non-proliferative diabetic retinopathy: a systematic review and meta-analysis
por: An, Xuedong, et al.
Publicado: (2020)

Polymeric immunoglobulin receptor (PIGR) exerts oncogenic functions via activating ribosome pathway in hepatocellular carcinoma
por: Zhang, Yuan, et al.
Publicado: (2021)

Using Traditional Chinese Medicine to Treat Hepatocellular Carcinoma by Targeting Tumor Immunity
por: Jia, Wentao, et al.
Publicado: (2020)

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma
por: Li, Yuyao, et al.
Publicado: (2022)

C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients
por: Zhang, Yuan, et al.
Publicado: (2021)

Is Traditional Chinese Medicine “Mainstream” in China? Trends in Traditional Chinese Medicine Health Resources and Their Utilization in Traditional Chinese Medicine Hospitals from 2004 to 2016
por: Shi, Xuefeng, et al.
Publicado: (2020)

Treating senile dementia with traditional Chinese medicine
por: Yan, Han, et al.
Publicado: (2007)

Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
por: Tao, Yuquan, et al.
Publicado: (2018)

Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol
por: Qiu, Ruijin, et al.
Publicado: (2021)

ETCM: an encyclopaedia of traditional Chinese medicine
por: Xu, Hai-Yu, et al.
Publicado: (2019)

Traditional Chinese medicine for cancer?
por: Ernst, E
Publicado: (2012)

Systematic Reviews and Meta-Analyses of Traditional Chinese Medicine Must Search Chinese Databases to Reduce Language Bias
por: Wu, Xin-Yin, et al.
Publicado: (2013)

Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis
por: Wu, Ping, et al.
Publicado: (2009)

The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
por: Jia, Wentao, et al.
Publicado: (2021)

Application of Traditional Chinese Medicine in Treatment of Atrial Fibrillation
por: Dong, Yan, et al.
Publicado: (2017)

Effectiveness, Medication Patterns, and Adverse Events of Traditional Chinese Herbal Patches for Osteoarthritis: A Systematic Review
por: Wang, Xuezong, et al.
Publicado: (2014)

Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro
por: Suo, Huizhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5vj98qd4mji6cp3qvfto3rraa0